NASDAQ · CBIO

Crescent Biopharma, Inc.

U.S. listed stock · USD15-minute delay

Find an instrument

Loading price chart…

Price chart by TradingView

15-minute delay. Chart times and available timeframes are controlled by the provider.

Earnings announcement for CBIO: Nov 5, 2026

−$4.01−$2.67−$1.34$0.00Sep 2025 estimate −$1.01Sep 2025 actual −$1.27 (-25.7% vs estimate)Sep 2025MissedDec 2025 estimate −$2.22Dec 2025 actual −$4.01 (-80.6% vs estimate)Dec 2025MissedMar 2026 estimate −$0.85Mar 2026 actual −$0.70 (+17.6% vs estimate)Mar 2026BeatJun 2026 estimate −$0.78Jun 2026 actual −$0.74 (+5.1% vs estimate)Jun 2026Beat estimate −$0.72
Estimated −$0.72 per shareActual Available Nov 5

Crescent Biopharma, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.72. The reported EPS for the same quarter last year was $-1.27.

Quarterly EPS forecasts
Fiscal quarter endConsensus EPS forecastHighLowEstimates
Sep 2026$-0.72$-0.64$-0.855
Dec 2026$-0.75$-0.65$-0.865
Mar 2027$-0.86$-0.74$-0.993
Jun 2027$-0.91$-0.81$-1.083

Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.

News

No recent stories for CBIO.

Company profile

Loading company profile…

Company profile by TradingView

Financials

Loading fundamental data…

Fundamental data by TradingView

More headlines

More stories for Crescent Biopharma, Inc. from TradingView. Coverage varies.

Loading related news…

Related news by TradingView

Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.